Neurologian yksikkö
Department of Neurology

Julkaisut 2006
Publications 2006

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aho L et al. Beta-amyloid aggregation in human brains with cerebrovascular lesions.
2 Alafuzoff I. Neuropatologinen tutkimus.
3 Alafuzoff I et al. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe consortium.
4 Alafuzoff I, Röyttä M. Histopatologiset tutkimukset neuroimmunologiassa.
5 Bendel P et al. Subarachnoid hemorrhage is followed by temoromesial voulume loss. MRI volumetric study.
6 Bhatt DL et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
7 Boccardi M. MRI Studies in Frontotemporal Dementia.
8 Braak H et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
9 Buerger K et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
10 Elovaara I et al., toim. Kliininen neuroimmunologia.
11 Erkinjuntti T et al., toim. Muistihäiriöt ja dementia. 2. uud. p.
12 Erkinjuntti T, Pirttilä T. Vaskulaariset dementiat.
13 Glauser T et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
14 Heikkinen T. Cognitive Effects of Estrogen in Ovariectomized, Aged and Transgenic Mice Modeling Alzheimer´s Disease.
15 Helisalmi S et al. Association of CYP46 intron 2 polymorphism in Finnish Alzheimer´s disease samples and a global scale summary.
16 Herukka S-K et al. Cerebrospinal fluid Abeta42, tau and phosphorylated tau predict progression in patients with cognitive impairment.
17 Hietanen M, Hänninen T. Laaja neuropsykologinen tutkimus.
18 Hiltunen M et al. Aromatase enzyme and Alzheimer´s disease.
19 Hu G et al. Body mass index and the risk of Parkinson disease.
20 Huhtiniemi T et al. Comparative and pharmacophore model for deacetylase SIRT1.
21 Hänninen T, Pulliainen V. Neuropsykologinen seulonta.
22 Iivonen S et al. Effects of estradiol on spatial learning, hippocampal cytochrome P450 19, and estrogen alpha and beta mRNA levels in ovariectomized female mice.
23 Jääskeläinen E et al. MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in finnish women.
24 Jönsson L et al. Patient- and proxy-reported utility in Alzheimer disease using the euroQoL.
25 Jönsson L et al. Determinants of costs of care for patients with Alzheimer´s disease.
26 Karhunen H et al. A long-term video-EEG and behavioral follow-up after endothelin-1 induced middle cerebral artery occlusion in rats.
27 Kauppinen T et al. Human postmortem brain tissue and 2-mm tissue microarrays.
28 Kerokoski P. Regulation of Cyclin-Dependent Kinase 5 (Cdk5). With Special Emphasis on Changes Occurring During Neuronal Cell Death.
29 Kivipelto M et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study.
30 Kivipelto M, Solomon A. Cerebral embolism and Alzheimer´s disease.
31 Kivipelto M, Solomon A. Cholesterol as a risk factor for Alzheimer´s disease - epidemiological evidence.
32 Kivipelto M et al. The new cholesterol controversy - a little bit of history repeating?
33 Kivipelto M et al. Alzheimer's Disease: back to the future.
34 Kiviranta PH et al. N,N´-bisbenzylidenebenzene-1,4-diamines and N,N´-bisbenzylidenenaphthalene-1,4-diamines as sirtuin type 2 (SIRT2) inhibitors.
35 Koivisto A. Genetic Components of Late-Onset Alzheimer´s Disease with Special Emphasis on ApoE, IL-6, CYP46, SERPINA3 and PPARgamma.
36 Koivisto AM et al. Association analysis of peroxisome proliferator-activated receptor gamma polymorphisms and late onset Alzhimer´s disease in the Finnish population.
37 Koponen H et al. Psykoosi- ja dementiapotilaiden oikeudellisen toimintakyvyn arviointi.
38 Korolainen M. Proteomic Analysis of Post-translationally Modified Proteins in Alzheimer´s Disease.
39 Korolainen MA et al. Oxidative modification of proteins in the frontal cortex of Alzheimer´s disease brain.
40 Kurl S et al. Metabolic syndrome and the risk of stroke in middle-aged men.
41 Kälviäinen R, Mervaala E. Epilepsiapotilaan tutkiminen.
42 Kälviäinen R, Tomson T. Optimizing treatment of epilepsy during pregnancy.
43 Kälviäinen R, Äikiä M. Epilepsia.
44 Laitinen MH et al. Fat intake at midlife and risk of dementia and Alzheimer´s disease: A population-based study.
45 Lensu S et al. Assessment by c-Fos immunostaining of changes in brain neural activity induced by 2, 3, 7, 8 -tetrachlorodibenzo-p-dioxin (TCDD) and leptin in rats.
46 Linnankivi T et al. Cerebroretinal microangiopathy with calcifications and cysts.
47 Martikainen P et al. Human brain tissue microarrays as a platform to investigate diseases of the nervous system.
48 Matell R, Pirttilä T. Myasthenia gravis (MG).
49 Miettinen R. Harhattomat stereologiset menetelmät rakenteiden mikroskooppisessa kvantitaatiossa.
50 Mäki-Petäjä-Leinonen A et al. Dementoituvan ihmisen oikeudellinen toimintakyky ja sen lääketieteellinen arviointi.
51 Mäkinen S et al. Human umbilical cord blood cells do not improve sensorimotor of cognitive outcome following transient middle cerebral artery occlusion in rats.
52 Nuutinen J et al. Assessing the outcome of stroke: a comparison between MRI and clinical strole scales.
53 Nystedt J et al. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats.
54 Oksman M et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
55 Oksman M et al. Brain reward in the absence of alpha-synuclein.
56 Pantoni L et al. Postmortem examination of vascular lesions in cognitive impairment - A survey among neuropathological services.
57 Parviainen I et al. Propofol in the treatment of refractory status epilepticus.
58 Pennanen C. Brain Atrophy in Mild Cognitive Impairment. MRI Volumetric and Voxel-based Method Study.
59 Pennanen C et al. The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: A voxel-based morphometric study.
60 Pirttilä T, ed. The Fourth Kuopio Alzheimer Symposium. Microteknia, Kuopio, Finland, February 2-4, 2006. Program and Abstracts.
61 Pirttilä T. Muistihäiriöistä ja dementiasta - missä mennään?
62 Pirttilä T. Kliininen tutkimus.
63 Pirttilä T. Laboratoriotutkimukset.
64 Pirttilä T. Biologiset merkkiaineet.
65 Pirttilä T, Elovaara I. Immunofarmakologiaa.
66 Pirttilä T, Erkinjuntti T. Alzheimerin taudin kliininen kuva ja diagnoosi.
67 Pirttilä T et al. MS-taudin oireet, taudinkuva ja toteaminen.
68 Pirttilä T, Soilu-Hänninen M. Perifeerisen hermon immunologia.
69 Popovic M et al. Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis.
70 Rastas S et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older.
71 Rissanen A et al. Prolonged bihemispheric alterations in unfolded protein response related gene expression after experimental stroke.
72 Saarela T et al. Plasma cell membrane glycoprotein-1 K121Qmpolymorphism in preeclampsia.
73 Saarela T et al. Adiponectin gene haplotype is associated with preeclampsia.
74 Saarela T et al. Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia.
75 Siegemund T et al. Thioflavins released from nanoparticles target fibrillar amyloid beta in the hippocampus of APP/PS1 transgenic mice.
76 Sillanpää M et al. Temporal changes in the incidence of epilepsy in Finland: nationwide study.
77 Soininen H. Mikä on näyttö yli 80-vuotiaiden dementian hoidosta.
78 Soininen H. Muistihäiriöiden ja dementian ennaltaehkäisy.
79 Soininen H, Hänninen T. Muistihäiriöiden oirediagnostiikka.
80 Soininen H, Partanen J. Kliinis-neurofysiologiset tutkimukset.
81 Sonninen R et al. Gene expression profiling in the hippocampus of rats subjected to focal cerebral ischemia and enriched environment housing.
82 Stroke PREVENTION By Aggressive Reduction in Cholesterol Levels (sparcl) Investigators. High-dose atorvastatin after stroke of transient ischemic attack.
83 Suomalaisen Lääkäriseura Duodecimin ja, Suomen Neurologinen Yhdistys ry:n asettama työryhmä. Aivoinfarkti. Käypä-hoito -suositus.
84 Suuronen T et al. Characterization of the pro-inflammatory signaling induced by protein acetylation in microglia.
85 Tervo AJ et al. Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.
86 Tuhkanen H et al. Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas.
87 van Groen T et al. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
88 Vanhanen M et al. Association of metabolic syndrome with Alzheimer disease: a population-based study.
89 Viinikainen K et al. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
90 Viinikainen K et al. Community-based, prostective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
91 Wilson IA et al. Neurocognitive aging: prior memories hinder new hippocampal encoding.
92 Winblad B et al. 3-Year study of Donepezil therapy in Alzheimer´s Disease: Effects of early and continuous therapy.
93 Yavich L et al. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P trasgenic mice.
94 Ylinen A et al. Kognitiivisten toimintojen neurobiologinen tausta.
95 Zhou X-W et al. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
96 Äikiä M et al. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
97 Äikiä M et al. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008